Zurich - Researchers from the University of Zurich are working with Airbus to send human stem cells to the International Space Station. Tissue is to be grown from these stem cells. At the moment, this is still just an experiment. However, in future, industrial production of human tissue could take place in space.

Researchers from the University of Zurich (UZH) are working with Airbus on a project to artificially grow human tissue. The aim is to use human stem cells for the production of three-dimensional organoids. To achieve this, the team is carrying out experiments in space. “On Earth, three-dimensional organoids are impossible to produce without support and matrix structures due to Earth’s gravity”, explains biologist Cora Thiel in a press release.

Researchers seeking to grow tissue in space
Launch of the re-supply mission Space X CRS-20 from Cape Canaveral, USA on March 6, 2020: The first UZH-Airbus experiment "Organoids in Space" is transported to the ISS. (Image: NASA)

In March 2020, a total of 250 test tubes containing human stem cells was sent to the International Space Station (ISS) as part of the project. This proved to be highly successful, with organ-like structures such as liver, bones and cartilage having been developed from these stem cells.

Now the focus will be on sending tissue stem cells from two women and two men of different ages into space. The aim here is to test how robust the method is when cells of diverse biological variability are used. The cells are set to return to Earth in early October, with initial findings then expected from November onwards.

“In view of future commercialization, we now need to find out how long and in what quality we can keep the organoids in culture after their return to Earth”, explains Oliver Ullrich, Professor of Anatomy at UZH. If successful, the technology will then be developed to the stage of operational maturity.

In future, space could become a workshop for human tissue, UZH writes in the press release. The tissues developed there could, for example, be used in the development of new drugs or even as building blocks for tissue replacement to treat damaged organs. At present, the number of organ donations is “far below” the level required to meet global demand.

Where life sciences meet innovation

Where life sciences meet innovation

Do you want to be close to major players, innovative start-ups and leading research institutes in the life sciences space? The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?  
info@greaterzuricharea.com